Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.97
-0.32 (-4.39%)
Aug 7, 2025, 12:49 PM - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $462.51 million as of August 7, 2025. Its market cap has decreased by -1.55% in one year.
Market Cap
462.51M
Enterprise Value
792.07M
1-Year Change
-1.55%
Ranking
Category
Stock Price
$6.97
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $462.51M, a decrease of -35.17%. That is a compound annual growth rate of -9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 483.75M | -29.52% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |